[Uric acid and purine plasma levels as plausible markers for placental dysfunction in pre-eclampsia].

Abstract

Uric acid is the final metabolite of purine break down, such as ATP, ADP, AMP, adenosine, inosine and hypoxanthine. The metabolite has been used broadly as a renal failure marker, as well as a risk factor for maternal and neonatal morbidity during pre-eclamptic pregnancies. High purine levels are observed in pre-eclamptic pregnancies, but the sources of these purines are unknown. However, there is evidence that pre-eclampsia (mainly severe pre-eclampsia) is associated with an increased release of cellular fragments (or microparticles) from the placenta to the maternal circulation. These in fact could be the substrate for purine metabolism. Considering this background, we propose that purines and uric acid are part of the same physiopathological phenomenon in pre-eclampsia (i.e., placental dysfunction) and could become biomarkers for placental dysfunction and postnatal adverse events.

• Authors: Carlos Escudero, Patricio Bertoglia, Felipe Muñoz, James M Roberts
• Journal: Revista medica de Chile (Rev Med Chil) Vol. 141 Issue 7 Pg. 895-902 (Jul 2013) ISSN: 0717-6163 [Electronic] Chile
• Vernacular Title: Purinas y ácido úrico en pre-eclampsia: interacciones fisiopatológicas y proyecciones en investigación.
• PMID: 24356738 (Publication Type: English Abstract, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Biomarkers
• Purines
• Uric Acid
• purine

Topics

• Biomarkers (blood)
• Female
• Humans
• Placenta (physiopathology)
• Pre-Eclampsia (blood, physiopathology)
• Pregnancy
• Purines (blood)
• Uric Acid (blood)